Zhi-Gang Zhang1, Fei Chen2, Jian-Zhong Chen1. 1. Department of Pharmacology, Liaocheng People's Hospital of Shandong Province, Liaocheng, 252000, China. 2. Department of Pharmacology, Liaocheng People's Hospital of Shandong Province, Liaocheng, 252000, China. 15116518@qq.com.
Abstract
BACKGROUND: This study aimed to investigate the effect of antibiotic stewardship programs (ASP) on reducing antimicrobial resistance rate, antibiotics consumption and multi-drug resistance bacterial infections in the pediatric patients. METHODS: This study was carried out in the Pediatric Center of a tertiary hospital of Shandong Province, China. The study duration was separated into two periods according to introduction of ASP (began from April 2011). Before intervention: from April 2009 to March 2011; after intervention: from April 2012 to March 2014. The consumption of antibiotics, defined daily dose (DDD), isolation of multidrug-resistant organisms (MDRO) and resistance rate of antibiotics were analyzed and compared between the two study periods. RESULTS: Total antibiotics consumption (DDDs) reduced from 56,725 in 2011 to 31,380 in 2014; antibiotic use density (AUD) reduced from 93.8 to 43.5; mean (± SD) antibiotic costs per patient (per quarter) decreased from 637 (± 29) RMB to 462 (± 49) RMB; and the mean total drug consumption (g)/DDD (DDDs) for inpatients decreased from 90.4 (± 3.3) to 56.4 (± 9.5). Multidrug-resistant microorganisms isolation reduced significantly from 463 (20.0) to 216 (6.9%). Resistance rate of general spectrum antibiotics reduced remarkably after intervention. The proportion of patients colonized or infected with Carbapenems-resistant Acinetobacter baumannii was correlated with DDDs of carbapenem. CONCLUSIONS: Implementation of ASP leads to reduced medical expense, decrease of improper and abuse of antibiotics, and reduced antibiotics resistance rate and MDRO isolation. Continuous efforts to improve antibiotic use are required.
BACKGROUND: This study aimed to investigate the effect of antibiotic stewardship programs (ASP) on reducing antimicrobial resistance rate, antibiotics consumption and multi-drug resistance bacterial infections in the pediatric patients. METHODS: This study was carried out in the Pediatric Center of a tertiary hospital of Shandong Province, China. The study duration was separated into two periods according to introduction of ASP (began from April 2011). Before intervention: from April 2009 to March 2011; after intervention: from April 2012 to March 2014. The consumption of antibiotics, defined daily dose (DDD), isolation of multidrug-resistant organisms (MDRO) and resistance rate of antibiotics were analyzed and compared between the two study periods. RESULTS: Total antibiotics consumption (DDDs) reduced from 56,725 in 2011 to 31,380 in 2014; antibiotic use density (AUD) reduced from 93.8 to 43.5; mean (± SD) antibiotic costs per patient (per quarter) decreased from 637 (± 29) RMB to 462 (± 49) RMB; and the mean total drug consumption (g)/DDD (DDDs) for inpatients decreased from 90.4 (± 3.3) to 56.4 (± 9.5). Multidrug-resistant microorganisms isolation reduced significantly from 463 (20.0) to 216 (6.9%). Resistance rate of general spectrum antibiotics reduced remarkably after intervention. The proportion of patients colonized or infected with Carbapenems-resistant Acinetobacter baumannii was correlated with DDDs of carbapenem. CONCLUSIONS: Implementation of ASP leads to reduced medical expense, decrease of improper and abuse of antibiotics, and reduced antibiotics resistance rate and MDRO isolation. Continuous efforts to improve antibiotic use are required.
Entities:
Keywords:
Antibiotic stewardship program (ASP); Antimicrobial resistance; Defined daily dose (DDD); Isolation of multidrug-resistant organisms (MDRO)
Authors: Wenshuang Zhang; Xuzhuang Shen; Yi Wang; Yuan Chen; Min Huang; Qiyi Zeng; Jinghai Wei; Quan Lu; Gang Wang; Li Deng; Xiaohong Wang; Kaihu Yao; Sangjie Yu; Yonghong Yang Journal: Pharmacoepidemiol Drug Saf Date: 2008-03 Impact factor: 2.890
Authors: Anurag N Malani; Patrick G Richards; Shikha Kapila; Michael H Otto; Jennifer Czerwinski; Bonita Singal Journal: Am J Infect Control Date: 2012-05-10 Impact factor: 2.918
Authors: Naina Bhalla; Nagham Hussein; Maha Atari; Rasheed M Fakhri; Chiara Lepora; Nadia Walsh; Sara E Cosgrove; Richard A Murphy Journal: Am J Infect Control Date: 2016-05-17 Impact factor: 2.918
Authors: Y Muraki; M Kitamura; Y Maeda; T Kitahara; T Mori; H Ikeue; M Tsugita; K Tadano; K Takada; T Akamatsu; T Yamada; T Yamada; T Shiraishi; M Okuda Journal: Infection Date: 2013-03-08 Impact factor: 3.553
Authors: Peter Davey; Erwin Brown; Esmita Charani; Lynda Fenelon; Ian M Gould; Alison Holmes; Craig R Ramsay; Philip J Wiffen; Mark Wilcox Journal: Cochrane Database Syst Rev Date: 2013-04-30
Authors: Pim Wilhelmus Maria van Dorst; Simon van der Pol; Olawale Salami; Sabine Dittrich; Piero Olliaro; Maarten Postma; Cornelis Boersma; Antoinette Dorothea Isabelle van Asselt Journal: BMJ Open Date: 2022-02-21 Impact factor: 2.692